Randomized Evaluation of Paclitaxel-eluting versus Everolimus-eluting stent Trial

Randomized Evaluation of Paclitaxel-eluting versus Everolimus-eluting stent Trial - Rapeet study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004177

Enrollment

800

Registered

2010-09-08

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Paclitaxel-eluting stent Evalorimus-eluting stent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Undergoing of drug-eluting stent implantation

Exclusion criteria

Exclusion criteria: No candiated for drug-eluing stent implantation

Design outcomes

Primary

Measure	Time frame
Taget vessel revascularization	—

Countries

Japan

Contacts

Public ContactKeizo Kimura

Wakayama Medical University Division of Cardiovascular Medicine

k0301crm@wakayama-med.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026